|
YTHDC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.642400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.843200E-01 |
| Normal-vs-Stage2 |
7.005600E-01 |
| Normal-vs-Stage3 |
1.683430E-01 |
| Normal-vs-Stage4 |
2.581000E-01 |
| Stage1-vs-Stage2 |
9.240600E-01 |
| Stage1-vs-Stage3 |
4.059400E-01 |
| Stage1-vs-Stage4 |
5.759800E-01 |
| Stage2-vs-Stage3 |
4.368000E-01 |
| Stage2-vs-Stage4 |
5.240400E-01 |
| Stage3-vs-Stage4 |
9.788600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.060600E-01 |
| Normal-vs-AfricanAmerican |
5.970000E-01 |
| Normal-vs-Asian |
4.479400E-01 |
| Caucasian-vs-AfricanAmerican |
8.465000E-01 |
| Caucasian-vs-Asian |
7.038000E-01 |
| AfricanAmerican-vs-Asian |
7.468000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.763800E-01 |
| Normal-vs-Female |
8.416400E-01 |
| Male-vs-Female |
2.685800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.187800E-01 |
| Normal-vs-Extreme_Weight |
1.834190E-01 |
| Normal-vs-Obese |
8.975200E-01 |
| Normal-vs-Extreme_Obese |
1.303570E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.489000E-01 |
| Normal_Weight-vs-Obese |
5.729000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.905200E-01 |
| Extreme_Weight-vs-Obese |
2.146600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.005200E-01 |
| Obese-vs-Extreme_Obese |
2.291200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.272000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.579200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.579600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.007040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.749000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.559800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.142630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.930300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.198770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.385400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.183200E-01 |
| Normal-VS-Type2 PRCC |
6.176700E-04 |
| Normal-VS-KIRP CIMP |
1.001980E-01 |
| Normal-VS-Unclassified PRCC |
8.275400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.75230000509785E-08 |
| Type1 PRCC-VS-KIRP CIMP |
7.914200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.076200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.072400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.161800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.832190E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.808090E-02 |
| Normal-vs-N1 |
7.226800E-01 |
| Normal-vs-N2 |
4.94039999998641E-06 |
| N0-vs-N1 |
1.020640E-01 |
| N0-vs-N2 |
4.322000E-03 |
| N1-vs-N2 |
2.215600E-03 |
|
|
